Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket
Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) rose sharply in today's pre-market trading after the company announced expanded US FDA approval of ELEVIDYS to Duchenne Muscular Dystrophy patients ages 4 and above.
Sarepta Therapeutics shares climbed 35.2% to $166.96 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- Spectaire Holdings Inc (NASDAQ:SPEC) rose 110% to $0.7140 in pre-market trading after the company announced a purchase order and delivery of its advanced AireCore units to American Ag Energy.
- DermTech, Inc. (NASDAQ:DMTK) gained 105.5% to $0.2423 in pre-market trading after declining 19% on Thursday. DermTech recently filed for Chapter 11 protection and implemented a 20% workforce reduction to preserve cash.
- Trinity Place Holdings Inc. (NYSE:TPHS) shares rose 35.7% to $0.1740 in pre-market trading after gaining more than 5% on Thursday.
- Barinthus Biotherapeutics PLC – ADR (NASDAQ:BRNS) shares rose 25.5% to $1.57 in pre-market trading after dipping 26% on Thursday.
- Zoomcar Holdings, Inc. (NASDAQ:ZCAR) rose 22.5% to $0.1791 in pre-market trading. Zoomcar announced closing of sale of $3.6 million notes private placement.
- Ondas Holdings Inc. (NASDAQ:ONDS) gained 16.6% to $0.77 in pre-market trading after declining around 10% on Thursday.
- Lion Group Holding Ltd – ADR (NASDAQ:LGHL) shares gained 13.1% to $0.44 in pre-market trading.
- Solid Biosciences Inc (NASDAQ:SLDB) shares rose 11.9% to $7.05 in pre-market trading after falling over 7% on Thursday.
- Clover Health Investments, Corp. (NASDAQ:CLOV) shares climbed 7.8% to $1.11 in pre-market trading following insider buying from the company's co-founder. After the market close on Thursday, Clover Health filed a Form 4 with the SEC showing that co-founder and executive chair Vivek Garipalli purchased 877,567 shares of Clover Health stock at an average price of $1.14 per share.
Losers
- Psyence Biomedical Ltd. (NASDAQ:PBM) shares fell 23.6% to $0.4547 in pre-market trading after gaining 6% on Thursday.
- Professional Diversity Network, Inc. (NASDAQ:IPDN) shares fell 21.1% to $0.5102 in pre-market trading after dipping around 14% on Thursday.
- SMX (Security Matters) Public Limited Company (NASDAQ:SMX) shares declined 18.5% to $0.1310 in pre-market trading after gaining 35% on Thursday.
- Ensysce Biosciences, Inc. (NASDAQ:ENSC) shares fell 17.6% to $0.4544 in pre-market trading.
- Reliance Global Group, Inc. (NASDAQ:RELI) shares fell 16.8% to $0.5021 in pre-market trading. Reliance Global shares jumped 54% on Thursday after the company announced an institutional investor has redeemed all of its outstanding Series B and Series G warrants.
- MGO Global, Inc. (NASDAQ:MGOL) fell 16% to $0.6296 in pre-market trading. MGO Global shares jumped 63% on Thursday after the company and Heidmar entered an agreement for a business combination.
- Trevena, Inc. (NASDAQ:TRVN) shares declined 13.1% to $0.2138 in pre-market trading after dipping over 30% on Thursday. Trevena announced preclinical TRV045 data for long-term analgestic effect in prelinical model of neuropathic pain.
- Molecular Partners AG (NASDAQ:MOLN) shares dipped 12.7% to $9.61 in pre-market trading after jumping over 38% on Thursday.
- NANO Nuclear Energy Inc. (NASDAQ:NNE) shares fell 9.7% to $13.74 in pre-market trading after surging 31% on Thursday.
- VinFast Auto Ltd. (NASDAQ:VFS) fell 7.9% to $3.97 in pre-market trading after gaining 10% on Thursday.
Now Read This: Top 4 Consumer Stocks that May Keep You Up At Night This Month